MDNA-113

N/A

Report date: 2025/02/13 10:20:09
First In Class

Base Information

Drug NameMDNA-113
Drug Alias NameMDNA-113MDNA113
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-13 receptor subunit alpha-2 modulatorsAnti-PD-1
TargetsInterleukin-13 receptor subunit alpha-2Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A